See It All. Understand It All.
Published loading...Updated

U.S. FDA removes COVID test requirements for Pfizer, Merck pills

Summary by Ground News
Pfizer's Paxlovid and Merck's Lagevrio pills were given emergency use authorizations in Dec. 2021. FDA said the patients should have a current diagnosis of mild-to-moderate COVID infection. Individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID even if they have a negative test result.

Bias Distribution

  • 67% of the sources are Center
67% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Reuters broke the news in United Kingdom on Wednesday, February 1, 2023.
Sources are mostly out of (0)

Similar News Topics